Schizophrenia Clinical Trial
Official title:
The Potential Efficacy and Acceptability of the Chinese Health Improvement Profile (CHIP) in Improving the Physical Health of People With Severe Mental Illness - A Pilot Clustered Randomised Controlled Trial
The investigators programme of research will evaluate an existing physical health care
screening intervention with the aim of helping Community Psychiatric Nurses (CPN) to improve
the physical health wellbeing of people with a SMI.
This pilot clustered randomised controlled trial aims to establish the potential efficacy and
acceptability of the Chinese Health Improvement Profile (CHIP) in improving the physical
health of people with severe mental illness.
This pilot study will use a non-blinded parallel group clustered randomised controlled trial
design.
The study will be carried out by CPNs with community-dwelling people aged 18-65 who have a
psychiatric diagnosis of SMI (i.e. schizophrenia, schizoaffective disorder, other psychotic
disorder or bipolar affective disorder) and at the point of recruitment are being treated in
the community. It will investigate the potential clinical impact of the use of the CHIP tool
when used by CPNs with this patient group. Because the CHIP is designed to be used as both an
enhanced physical health risk screening tool and as an instrument to direct appropriate
clinical interventions the investigators will ask the patients' allocated CPNs to recruit
consenting patients , collect outcome measure data and where appropriate use the CHIP tool
with patients that they work with within their routine clinical practice.
Primary objective:
To test the potential efficacy and acceptability of the CHIP intervention compared to
treatment as usual on patients' physical well- being over a 12 month period.
Secondary objectives:
To measure and compare changes in perceived mental well-being between the groups as measured
at baseline, and at 6 months and 12 months after the start of the intervention.
To establish differences in the objective physical health state of patients between the
groups at 12 months as indicated by data routinely recorded in medical/outpatient/nursing
notes during the duration of study.
To establish changes in health behaviours and physical indicators of cardiovascular risk
within the intervention group between baseline and 12 months after the start of the
intervention.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |